Lower CMV and EBV Exposure in Children With Kawasaki Disease Suggests an Under-Challenged Immune System
- PMID: 33585370
- PMCID: PMC7873854
- DOI: 10.3389/fped.2020.627957
Lower CMV and EBV Exposure in Children With Kawasaki Disease Suggests an Under-Challenged Immune System
Erratum in
-
Corrigendum: Lower CMV and EBV Exposure in Children With Kawasaki Disease Suggests an Under-Challenged Immune System.Front Pediatr. 2021 Sep 10;9:765546. doi: 10.3389/fped.2021.765546. eCollection 2021. Front Pediatr. 2021. PMID: 34568246 Free PMC article.
Abstract
Background: Kawasaki Disease (KD) is a pediatric vasculitis of which the pathogenesis is unclear. The hypothesis is that genetically pre-disposed children develop KD when they encounter a pathogen which remains most often unidentified or pathogen derived factors. Since age is a dominant factor, prior immune status in children could influence their reactivity and hence the acquisition of KD. We hypothesized that systemic immune responses early in life could protect against developing KD. With this study we tested whether the incidence of previous systemic cytomegalovirus (CMV) or Epstein-Barr virus (EBV) infection is lower in children with KD compared to healthy age-matched controls. Methods and Results: We compared 86 KD patients with an age-matched control group regarding CMV and EBV VCA IgG measurements (taken before or 9 months after IVIG treatment). We found that both CMV and EBV had an almost 2-fold lower seroprevalence in the KD population than in the control group. Conclusions: We suggest that an under-challenged immune system causes an altered immune reactivity which may affect the response to a pathological trigger causing KD in susceptible children.
Keywords: Epstein-Barr virus; Kawasaki disease; cytomegalovirus; immune system; viral exposure.
Copyright © 2021 van Stijn-Bringas Dimitriades, Slegers, Zaaijer and Kuijpers.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Emerging evidence of microbial infection in causing systematic immune vasculitis in Kawasaki disease.Front Microbiol. 2023 Dec 22;14:1313838. doi: 10.3389/fmicb.2023.1313838. eCollection 2023. Front Microbiol. 2023. PMID: 38188572 Free PMC article. Review.
-
Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity.Lupus. 2020 Sep;29(10):1263-1269. doi: 10.1177/0961203320940029. Epub 2020 Jul 9. Lupus. 2020. PMID: 32646294
-
Kawasaki disease with a concomitant primary Epstein - Barr virus infection.Pediatr Rheumatol Online J. 2020 Aug 12;18(1):65. doi: 10.1186/s12969-020-00459-0. Pediatr Rheumatol Online J. 2020. PMID: 32787862 Free PMC article.
-
Epstein-Barr virus antibodies in Kawasaki disease.Yonsei Med J. 2006 Aug 31;47(4):475-9. doi: 10.3349/ymj.2006.47.4.475. Yonsei Med J. 2006. PMID: 16941735 Free PMC article.
-
Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized Immunotherapies.Front Cell Dev Biol. 2020 Jan 23;7:362. doi: 10.3389/fcell.2019.00362. eCollection 2019. Front Cell Dev Biol. 2020. PMID: 32039196 Free PMC article. Review.
Cited by
-
Emerging evidence of microbial infection in causing systematic immune vasculitis in Kawasaki disease.Front Microbiol. 2023 Dec 22;14:1313838. doi: 10.3389/fmicb.2023.1313838. eCollection 2023. Front Microbiol. 2023. PMID: 38188572 Free PMC article. Review.
-
Associations of infection burden with Kawasaki disease in a population-based setting during 30 years.RMD Open. 2025 Jan 20;11(1):e005160. doi: 10.1136/rmdopen-2024-005160. RMD Open. 2025. PMID: 39837621 Free PMC article.
References
-
- McCrindle BW, Manlhiot C, Newburger JW, Harahsheh AS, Giglia TM, Dallaire F, et al. . Medium-term complications associated with coronary artery aneurysms after kawasaki disease: a study from the international kawasaki disease registry. J Am Heart Assoc. (2020) 9:e016440. 10.1161/jaha.119.016440 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources